(Q38011646)

27 August 2017

title

Chemerin: a potential endocrine link between obesity and type 2 diabetes (English)

1 reference

27 August 2017

0 references

0 references

Alexandra A Roman

1

1 reference

27 August 2017

Sebastian D Parlee

series ordinal

2

1 reference

27 August 2017

Christopher J Sinal

series ordinal

3

1 reference

27 August 2017

publication date

19 May 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

42

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

243-251

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9698-8

27 August 2017

exact match

0 references

cites work

Epidemiology and economic impact of obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

What causes the insulin resistance underlying obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

The development and endocrine functions of adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Adiponectin action from head to toe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Vaspin in obesity and diabetes: pathophysiological and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Obesidomics: contribution of adipose tissue secretome analysis to obesity research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Apelin, diabetes, and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Associations between glucose tolerance, insulin sensitivity and insulin secretion phenotypes and polymorphisms in adiponectin and adiponectin receptor genes in the Quebec Family Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin: at the crossroads of inflammation and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Effect of bariatric surgery on circulating chemerin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Insulin and metformin regulate circulating and adipose tissue chemerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

The genetic design of signaling cascades to record receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Quantification of angiotensin-converting-enzyme-mediated degradation of human chemerin 145-154 in plasma by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Identification of a stable chemerin analog with potent activity toward ChemR23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Chemerin regulates β-cell function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

The association of serum chemerin level with risk of coronary artery disease in Chinese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9698-8

Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1

21 January 2018

1 reference

12 December 2020

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues

1 reference

12 December 2020

Altered Plasma Adipokine Levels andin VitroAdipocyte Differentiation in Pediatric Type 1 Diabetes

1 reference

12 December 2020

Resistin level in coronary artery disease and heart failure: the central role of kidney function

1 reference

12 December 2020

Adipocytokines - novel link between inflammation and vascular function?

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Obesity as a medical problem

1 reference

12 December 2020

Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease

1 reference

12 December 2020

Chemerin, vaspin and insulin resistance in chronic hepatitis C

1 reference

12 December 2020

Circulating level of chemerin is upregulated in psoriasis

1 reference

12 December 2020

Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study

1 reference

12 December 2020

10.1007/S12020-012-9698-8

Identifiers

DOI

1 reference

27 August 2017

1 reference